| |
 |
 |
| May 2005 |
| |
 |
| |
| Serological Tests for Detecting Natural Heartworm Infection in Cats |
Serological tests were performed on 380 cats with necropsy-confirmed heartworm status to
compare the performance of currently available commercial laboratory and point-of-care heart-worm serological
tests in an heartworm-endemic area. Overall, antigen tests detected 79.3% to 86.2% of heartworm infections and
were highly specific. Most cats with false-negative antigen tests had a single male worm. Antibody tests
detected 62.1% to 72.4% of heartworm infections and had a wider range of false-positive results (1.4% to 19.1%)
than antigen tests (0.3% to 2.0%). Serological tests for feline heartworm infection varied in diagnostic performance.
Combining results from antigen and antibody tests achieved greater sensitivity than using either test alone.
Reference: Berdoulay et al, JAAHA 40:376-384, 2004.
|
| |
| C-reactive Protein Differentiates Pyometra From Cystic Endometrial
Hyperplasia in Dogs |
|
Hematological parameters, plasma C-reactive protein (CRP), and tumor necrosis factor were analyzed
in 64 dogs with a presumptive diagnosis of pyometra. Final diagnosis (i.e., pyometra or cystic endometrial
hyperplasia]) was determined by histopathology. As a single test, the percentage of band neutrophils had
the highest sensitivity in the prediction of pyometra (sensitivity, 94%). The combination of percentage
of bands and CRP had the highest sensitivity (97.7%; specificity, 75%) in predicting the presence of
pyometra. The most common clinical signs noted in the study were vaginal discharge, polyuria, polydipsia,
lethargy, and gastrointestinal signs. A combination of three or more of these clinical signs was significantly
associated with pyometra.
Reference: Fransson et al, JAAHA 40:391-399, 2004.
|
| |
| Immunogenicity of Dietary Proteins in Cats and Influence
of the Canning Process |
The antigen-specific immune response to dietary proteins in 14 healthy
domestic shorthair cats was characterized, and compared when those proteins were fed unprocessed
or as part of a canned diet. The cats were fed 2 dietary proteins (soy and casein) either as
unprocessed aqueous suspensions or as part of canned diets for 21 days. Serum IgG and IgA and
salivary IgA were assayed by indirect ELISA, and antigen-specific proliferation of mesenteric
lymph node-derived lymphocytes was determined. Robust serum IgG and IgA responses to dietary
proteins were elicited, irrespective of the form in which they were fed. Salivary IgA responses
to unprocessed proteins were not detected. However, a significant salivary IgA response to the
protein isolated from the canned casein diet was observed in cats fed canned casein but not in
those fed unprocessed casein. Lymphocyte proliferation to the antigens was slight, and there were
no significant differences between groups. Results indicated that cats develop robust serum IgG
and IgA responses to dietary proteins when fed as either aqueous suspensions or as part of canned
diets. For certain proteins, there may be an increase and a qualitative difference in the immunogenicity
of canned diets, compared with unprocessed proteins. Thus, canned diets may not be ideal for management
of cats with enteritis.
Reference: Cave and Marks, AJVR 65: 1427-1433, 2004.
|
| |
| Canine Inflammatory Myopathies: Review of 200 Cases |
A retrospective study was performed on 200 randomly selected cases of inflammatory
myopathy in dogs from diagnostic muscle biopsies received at the Comparative Neuromuscular Laboratory,
Univ. of CA, San Diego. The most common clinical signs were generalized weakness, stilted gait, dysphagia,
masticatory or generalized muscle atrophy, inability to open the jaw, megaesophagus, and dysphonia. Myalgia
was rarely described. Age of onset ranged from 0.25 to 14 years, and genders were equally represented. Breed
distribution approximated the 2002 AKC registration statistics (r = .85) with the notable exception of Boxers
and Newfoundlands. Average creatine kinase and aspartate aminotransferase concentrations in generalized
inflammatory myopathy cases were significantly higher than those with focal inflammatory myopathy (p < .05).
Neoplasia developed in 12 of 200 dogs within 12 months of diagnosis of polymyositis, with lymphoma diagnosed
in 6 of 32 Boxers. Inflammatory myopathy was associated with antibody titers against infectious diseases in
38 dogs. Neospora caninum and Hepatozoon americanum cysts were found in tissues of 2 dogs not serologically
tested. Antibodies against an unidentified sarcolemmal antigen were found in 9 of 19 Newfoundlands with
polymyositis. The spectrum of canine inflammatory myopathies can be broad, with infectious etiologies
relatively common, and can include pre-neoplastic and uncharacterized syndromes.
Reference: Evans, Levesque, and Shelton. JVIM 18: 679-691, 2004.
|
| |
| Efficacy and Safety of Transdermal Methimazole in Treating
of Cats with Hyperthyroidism |
The objective of this study was to determine whether transdermal methimazole
was as safe and effective as oral methimazole for controlling hyperthyroidism in cats. Forty-seven
cats with newly diagnosed hyperthyroidism were randomized to receive either transdermal methimazole
in pluronic lecithin organogel, or oral methimazole (2.5 mg q12h for either route). Cats were
evaluated at weeks 0, 2, and 4 with a physical exam, body weight, CBC, biochemical panel, urinalysis,
measurement of total T4, indirect Doppler blood pressure determination, and completion of owner questionnaire.
Data between the 2 groups and over time were compared by nonparametric methods. Forty-four cats followed
the protocol (17 oral and 27 transdermal). Significantly more cats treated with oral methimazole had serum
T4 concentrations within the reference range after 2 weeks (14 of 16 cats) compared to those treated by the
transdermal route (14 of 25; p = .027). This difference was no longer significant by 4 weeks of treatment
(9 of 11 for oral versus 14 of 21 for transdermal), possibly because of inadequate numbers evaluated by 4
weeks. Cats treated with oral methimazole had a higher incidence of gastrointestinal (GI) adverse effects
(4 of 17 cats) compared to cats treated with transdermal methimazole (1 of 27; p = .04), but no differences
were found between groups in the incidence of neutropenia, hepatotoxicity, or facial excoriations. Although
the overall efficacy of transdermal methimazole is not as high as that of oral methimazole at 2 weeks of
treatment, it is associated with fewer GI adverse effects compared to the oral route.
Reference: Sartor et al, JVIM 18: 651-655, 2004.
|
| |
| |
 |
 |
 |
| |
 |
Please send comments to the webmaster.
©1997-2008 Antech Diagnostics, Inc.
Site design and maintenance by amesDesign. |
|